ClinicalTrials.gg

Program

BBT001

A development code.

Its studies are mostly in Dermatitis, Atopic · Chronic Urticaria, led by Bambusa Therapeutics.

Furthest: phase 2, since Jul 16, 20263 company-led studies, 3 open or runningNext primary completion: Feb 28, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Bambusa Therapeutics33 open or runningphase 2since Jul 16, 2026Jan 30, 2025Feb 28, 2027phase 1 · NCT06808477

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 30, 2025First study: phase 1 study in Dermatitis, AtopicFirst studyNCT06808477 · 237 planned · United States, Australia, New Zealand and more
  2. Sep 28, 2025Phase 1 study in Dermatitis, AtopicNCT07239947 · 99 planned · China
  3. Jul 16, 2026Phase 2 study in Chronic UrticariaPhase 2 reachedNCT07717905 · 48 planned · China

Ahead

  1. Feb 28, 2027Primary completion: phase 1 study in Dermatitis, AtopicNCT06808477
  2. Dec 31, 2027Primary completion: phase 2 study in Chronic UrticariaNCT07717905
  3. Dec 31, 2027Primary completion: phase 1 study in Dermatitis, AtopicNCT07239947

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07717905Chronic Urticaria · China2RecruitingDec 31, 202748
NCT07239947Dermatitis, Atopic · China1RecruitingDec 31, 202799
NCT06808477Dermatitis, Atopic · United States, Australia, New Zealand and more1RecruitingFeb 28, 2027237

How it is read

Names in the registry

  • “BBT001”, 3 entries

Codes read as this program: BBT001.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.
BBT001 (Bambusa Therapeutics): development program | ClinicalTrials.gg